AAGILENT TECHNOLOGIES, INC.
- BusinessWire
CORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per Share
First paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly ...
- BusinessWire
Agilent to Participate in J.P. Morgan U.S. All Stars Conference
Agilent Technologies Inc. (NYSE:A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m. ...
- BusinessWire
Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
Agilent Technologies Inc. (NYSE:A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of ...
- BusinessWire
Agilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner System
The FDA-cleared system will strengthen Agilent's support for digital pathology laboratoriesAgilent Technologies Inc. (NYSE:A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide ...
- BusinessWire
Agilent Introduces the Cary 635 FTIR Spectrometer
A compact, user-friendly system designed for today’s laboratory demands Agilent Technologies, Inc. (NYSE:A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact, ...
- Analyst Upgrades
Stifel Maintains Buy on Agilent Technologies, Raises Price Target to $180
Stifel analyst Daniel Arias maintains Agilent Technologies with a Buy and raises the price target from $170 to $180. ...
- Analyst Upgrades
Citigroup Maintains Buy on Agilent Technologies, Raises Price Target to $190
Citigroup analyst Patrick Donnelly maintains Agilent Technologies with a Buy and raises the price target from $185 to $190. ...
- Analyst Upgrades
JP Morgan Maintains Overweight on Agilent Technologies, Raises Price Target to $190
JP Morgan analyst Casey Woodring maintains Agilent Technologies with a Overweight and raises the price target from $180 to $190. ...
- Analyst Upgrades
TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $180
TD Cowen analyst Dan Brennan maintains Agilent Technologies with a Buy and raises the price target from $155 to $180. ...
- Analyst Upgrades
Bernstein Maintains Outperform on Agilent Technologies, Raises Price Target to $180
Bernstein analyst Eve Burstein maintains Agilent Technologies with a Outperform and raises the price target from $155 to $180. ...
- Analyst Upgrades
RBC Capital Maintains Outperform on Agilent Technologies, Raises Price Target to $185
RBC Capital analyst Dan Leonard maintains Agilent Technologies with a Outperform and raises the price target from $155 to $185. ...
- Analyst Upgrades
Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $172
Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies with a Outperform and raises the price target from $148 to $172. ...
- BusinessWire
Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
Delivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Third-quarter fiscal year 2026 Revenue of $1.88 billion for the third ...
- Analyst Upgrades
Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $175
Morgan Stanley analyst Kallum Titchmarsh maintains Agilent Technologies with a Overweight and raises the price target from $160 to $175. ...
- BusinessWire
Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo
Eastern Institute of Technology professor recognized for advancing PFAS and emerging contaminant analysis Agilent Technologies Inc. (NYSE:A) today announced that the Eastern Institute of Technology, Ningbo has ...
- BusinessWire
Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26
Agilent Technologies Inc. (NYSE:A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. The company will host a conference call to discuss the ...
- BusinessWire
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab) Agilent Technologies Inc. (NYSE:A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3 ...
- BusinessWire
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
Test enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® Agilent Technologies Inc. (NYSE:A) today announced that it has ...
- BusinessWire
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
Agilent Technologies Inc. (NYSE:A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to ...
- Analyst Upgrades
Evercore ISI Group Maintains Outperform on Agilent Technologies, Raises Price Target to $148
Evercore ISI Group analyst Vijay Kumar maintains Agilent Technologies with a Outperform and raises the price target from $144 to $148. ...
- BusinessWire
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
Simplifying label-free imaging analysis for more confident real-time cell analysis Agilent Technologies Inc. (NYSE:A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module ...
- Analyst Upgrades
Bernstein Reinstates Outperform on Agilent Technologies, Announces $155 Price Target
Bernstein analyst Eve Burstein reinstates Agilent Technologies with a Outperform and announces $155 price target. ...
- GlobeNewswire
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
Denver, CO and London, UK – 25 June 2026: Excellere Partners ("Excellere"), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP ...
- BusinessWire
Agilent Completes Acquisition of Biocare Medical
Highly complementary combination expands Agilent’s pathology portfolio and ability to serve customers across clinical and research settingsExpected to be accretive to Agilent’s top-line growth rate, margin profile and ...
- Analyst Upgrades
Piper Sandler Initiates Coverage On Agilent Technologies with Neutral Rating, Announces Price Target of $150
Piper Sandler analyst David Westenberg initiates coverage on Agilent Technologies with a Neutral rating and announces Price Target of $150. ...